*By Jacqueline Corba* Former Massachusetts Governor Bill Weld called on President Trump to change the federal classification of marijuana so researchers can explore the drug's ability to treat diseases, including cancer. "I think anybody who is a reasonable politician has to listen to the argument that its been proved around the world that this will cure the ailments that your constituents are suffering from," Weld said in an interview with Cheddar at the Cannabis World Congress in New York. "Do you want to look your constituents in the eye, and say, 'No ー I'm going to stand in the way of you getting the physical relief from pain and suffering that you know you can get around the corner? That's a position that makes no political sense." According to the Drug Enforcement Administration, marijuana is a Schedule I drug, which is the same category as heroin, LSD, and ecstasy. This means it is considered to have a high potential for abuse and is not accepted for medical use. Weld, who is a member of the board of the cannabis company Acreage Holdings, said Washington has yet to catch up with the country when it comes to cannabis: 64 percent of Americans say it should be made legal, according to a [Gallup Poll](http://news.gallup.com/poll/221018/record-high-support-legalizing-marijuana.aspx). "There's a lot of old people who have pains and aches that cannabis is very useful in just making go away. They are a voting bloc," said Weld, who also said millennial voters are another large bloc in favor of legalization. "So that's a pretty good pair of bookend voting blocs for any politician that is listening." Weld said ultimately research will make it impossible for members of Congress to vote against cannabis, once they understand more about the drugs abilities. For the full interview, [click here](https://cheddar.com/videos/why-bill-weld-is-pushing-to-declassify-marijuana-as-schedule-i-drug).

Share:
More In Business
Celebrating AAPI: Entrepreneur Discusses Bringing Japanese Snacks to the World
Danny Taing, founder and CEO of Bokksu, joined Cheddar News to discuss his path on how he became an entrepreneur to launch a company that delivers artisanal Japanese snacks. "When I moved back from Japan to New York, I had this bit of reverse culture shock ... a lot of people had somewhat of a one-dimensional view of Japan ... they saw this country where people ate sushi every day ... none of that is true," he said.
WSJ: Food Workers Union Opposing Kroger-Albertson's Deal
The United Food and Commercial Workers union, one of the country's largest, opposed the planned merger between grocery chains Kroger and Albertson's, according to The Wall Street Journal, citing concerns about lack of information and the potential viability of stores upon closing.
Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Load More